News Release

IOF Medal of Achievement awarded to Professor Eugene McCloskey

International Osteoporosis Foundation recognizes UK researcher for original and outstanding achievements in the field of osteoporosis

Grant and Award Announcement

International Osteoporosis Foundation

Prof. Eugene McCloskey, Professor of Adult Bone Diseases at the University of Sheffield Metabolic Bone Centre was awarded the International Osteoporosis Foundation (IOF) Medal of Achievement at a ceremony on April 16 during the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases,.

The IOF Medal of Achievement is presented annually by IOF to honour an individual researcher who has significantly advanced the field of osteoporosis through his original and outstanding scientific contributions. The award underlines important aspects of IOF's mission - to increase understanding and awareness of osteoporosis and to promote medical innovation and improved care.

Professor Cyrus Cooper, Chair of the IOF Committee of Scientific Advisors, presented the award, stating "Eugene McCloskey is an acknowledged expert in the fields of vertebral fracture definition, osteoporosis epidemiology as well as non-invasive assessments of bone strength and fracture risk. His experience in the field has been of great value to the International Osteoporosis Foundation and to the greater osteoporosis community as a whole."

Professor McCloskey has worked in the field of calcium and bone disorders since 1986. He has contributed to the development of the FRAX tool for estimating fracture risk and the National Osteoporosis Guidance Group (NOGG). Professor McCloskey is President of the Bone Research Society, a Board member of the International Osteoporosis Foundation, the Sheffield Director of the Centre for Integrated Research in Musculoskeletal Ageing (CIMA), Chair of the NOGG Implementation Committee and a member of the National Specialty Group for Musculoskeletal Diseases. He has published over 250 peer-reviewed publications, book chapters and reviews.

###

About the World Congress on Osteoporosis, Osteoarthritis & Musculoskeletal Diseases (WCO-IOF-ESCEO 2016)

Held jointly by IOF and ESCEO, the Congress took place in Malaga, Spain from April 14-17, 2016. It is the world's largest annual forum for the presentation of clinical research and new advances in the prevention and management of bone, muscle and joint disorders, including sarcopenia and frailty. The next Congress will be held in Florence, Italy from March 23-26, 2017. For complete information visit http://www.wco-iof-esceo.org #OsteoCongress

About IOF:

The International Osteoporosis Foundation (IOF) is the world's largest nongovernmental organization dedicated to the prevention, diagnosis and treatment of osteoporosis and related musculoskeletal diseases. IOF members, including committees of scientific researchers, leading companies, as well as more than 234 patient, medical and research societies in 99 locations, work together to make bone, joint and muscle health a worldwide heath care priority. http://www.iofbonehealth.org / http://www.facebook.com/iofbonehealth / https://twitter.com/iofbonehealth

About ESCEO :

The European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) is a non-profit organization, dedicated to a close interaction between clinical scientists dealing with rheumatic disorders, pharmaceutical industry developing new compounds in this field, regulators responsible for the registration of such drugs and health policy makers, to integrate the management of osteoporosis and osteoarthritis within the comprehensive perspective of health resources utilization. The objective of ESCEO is to provide practitioners with the latest clinical and economic information, allowing them to organize their daily practice, in an evidence-based medicine perspective, with a cost-conscious perception. http://www.esceo.org


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.